Pain Sensitivity and Pruritus of Peripheral Nerves
Pain Sensitivity and Pruritus of Peripheral Nerves - Can we Differentiate These Signals by Use of Pharmacological Modulation and Human Experimental Research?
Previous research has demonstrated that itch and pain share several underlying neural pathways and signaling molecules. Understanding these common mechanisms is important for developing more effective therapeutic strategies targeting both sensations. Mepyramine, an antihistamine, has been reported to exert effects on both itch and pain perception. This study aims to investigate these effects using established experimental models of itch and pain. Itch will be induced using histamine, a naturally occurring substance in the human body, and spicules from the plant Mucuna pruriens (cowhage), while electrical stimulation will be used to assess pain-related responses. By combining these experimentais approaches, the project aims to better understand how mepyramine influences different sensory mechanisms. The overall purpose of this study is to evaluate the effects of mepyramine on experimentally induced itch and pain in healthy volunteers.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Aalborg
-
Gistrup, Aalborg, Dänemark, 9260
- Center for Neuroplasticity and Pain Faculty of Medicine, Aalborg University Selma Lagerløfs Vej 249 9260 Gistrup, Denmark
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Healthy men and women aged 18-60 years
- Speak and understand English
Exclusion Criteria:
-
Pregnancy or lactation
-
Drug addiction defined as any use of cannabis, opioids, or other drugs that may cause addiction.
-
History of peripheral or chronic pain conditions, neuropathy, neurological, dermatological, or psychiatric diagnoses that may affect the results.
- Moles, wounds, scars, or tattoos in the area to be treated or tested
- Current use of medications that may affect the trial such as antihistamines, painkillers, antidepressants, or anticonvulsants
- Use of antihistamines should be discontinued 72 hours before the experiment and all topical agents and emollients should be discontinued 24 hours before the experiment.
- Application of moisturizing lotion of the volar site of the forearms (24 hours before study start)
- Previous traumatic experience of an electrical accident
- Participation in any other research projects/studies 7 days before study start
- Known allergy/intolerance to mepyramine
- The subject is assessed as unable to engage in the necessary cooperation required by the study
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Interventions
This subproject will be conducted in one single session lasting approximately 4-5 hours. In each forearm of the participant, two 4x4 cm areas will be selected as Area of Interest (AOI). In these selected areas, the same cream will be applied for 1 hour. After the cream removal, itch will be induced using histamine and cowhage (the order of histamine and cowhage will be randomized). During the application of the substances, the itch/pain elicited will be monitored for 10 minutes using a VAS (Visual analog scale). After the removal of the substances, measurements of SBP, MEI, PTT MPT, MPS, and thermal sensitivity will be conducted. |
About 30 spicules will be applied on the selected areas and inserted manually Mepyramine cream 2% One drop of histamine will be applied on the selected areas and pierced with a lancet. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Measuring itch by computerized Visual Analog Scale Scoring
Zeitfenster: During Histamine/cowhage application
|
We will ask the subjects to rate the sensation of itch on a 100 mm VAS scale ranging from 0 to 100 where 0 indicates |
During Histamine/cowhage application
|
|
Superficial blood perfusion
Zeitfenster: Before pruritogen application
|
Before pruritogen application
|
|
|
Superficial blood perfusion
Zeitfenster: 1 minute after pruritogen removal
|
1 minute after pruritogen removal
|
|
|
Superficial blood perfusion
Zeitfenster: 1 minute after cream+pruritogen removal
|
1 minute after cream+pruritogen removal
|
|
|
Perception threshold tracking model (PTT)
Zeitfenster: Before cream application
|
Before cream application
|
|
|
Perception threshold tracking model (PTT)
Zeitfenster: 1 minute after cream removal
|
1 minute after cream removal
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Mechanically evoked itch (MEI)
Zeitfenster: 2 minute after pruritogen removal
|
MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force). |
2 minute after pruritogen removal
|
|
Mechanically evoked itch (MEI)
Zeitfenster: 2 minute after cream+pruritogen removal
|
MEI is measured by using mildly pruritic, non-painful von Frey nylon filaments of a predetermined intensity (generally 5-30 miliNewton of force). |
2 minute after cream+pruritogen removal
|
|
Mechanical Pain Thresholds (MPT)
Zeitfenster: 5 minute after pruritogen removal
|
This test is conducted using a pinprick set. The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN. |
5 minute after pruritogen removal
|
|
Mechanical Pain Thresholds (MPT)
Zeitfenster: 5 minute after cream+pruritogen removal
|
This test is conducted using a pinprick set. The set consists of 7 needles each with a diameter of 0.6 mm and different force applications: 8, 16, 32, 64, 128, 256, and 512 mN. |
5 minute after cream+pruritogen removal
|
|
Mechanical Pain Sensitivity (MPS)
Zeitfenster: 8 minute after pruritogen removal
|
This test is conducted with the same pinprick set used to test the MPT. |
8 minute after pruritogen removal
|
|
Mechanical Pain Sensitivity (MPS)
Zeitfenster: 8 minute after cream+pruritogen removal
|
This test is conducted with the same pinprick set used to test the MPT. |
8 minute after cream+pruritogen removal
|
|
Cold Detection Thresholds (CDT)
Zeitfenster: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Cold Detection Thresholds (CDT)
Zeitfenster: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Warm Detection Thresholds (WDT)
Zeitfenster: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Warm Detection Thresholds (WDT)
Zeitfenster: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Cold Pain Thresholds (CPT)
Zeitfenster: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Cold Pain Thresholds (CPT)
Zeitfenster: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Heat Pain Thresholds (HPT)
Zeitfenster: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Heat Pain Thresholds (HPT)
Zeitfenster: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
|
Pain to Supra-threshold Heat Stimuli (STHS)
Zeitfenster: 10 minute after pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after pruritogen removal
|
|
Pain to Supra-threshold Heat Stimuli (STHS)
Zeitfenster: 10 minute after cream+pruritogen removal
|
The tests of thermal sensation will all be conducted using a TSA2 (Medoc Ltd, Israel) thermal sensory testing device |
10 minute after cream+pruritogen removal
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- N-20260019
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .